News and Insights of 3D Printing and Manufacturing
Triastek, a Chinese 3D printing pharmaceutical company, has announced that its proprietary 3D printed non-vitamin K antagonist oral anticoagulant (NOAC), T20G, has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) as of February 27, 2025. This regulatory achievement follows an earlier IND approval from China’s National Medical Products Administration (NMPA) in January 2024.
Axtra3D, a developer of high-speed stereolithography (SLA) systems, has introduced four new dental resins, expanding its portfolio of validated materials for the Lumia X1 printer. The new additions—NextDent Model Sand, Pro3dure Splint 19.1 AO/MSI, Pro3dure Denture 14.2, and Pro3dure Crown & Bridge—are now available with optimized print profiles, aimed at increasing accuracy and production efficiency for digitally manufactured dental models, splints, dentures, and restorations.
A group of Chinese researchers have developed a novel approach for addressing erectile dysfunction (ED) using biomedical 3D printing.
At IDS 2025, Carbon, a U.S.-based developer of CLIP 3D printing, will showcase its latest advancements in automation, material technology, and workflow optimization, all designed to enhance the efficiency of dental labs. The company will introduce new features in its Automatic Operation (AO) Suite and unveil Lucentra, a solution for clear aligner production. These innovations aim to improve productivity and support scalable production in the dental industry.
Researchers at RWTH Aachen University’s Chair Digital Additive Production (DAP), working with the reACT alliance, are developing bioresorbable implants designed to fit each patient’s needs.
Stratasys Ltd. (NASDAQ: SSYS), a manufacturer of polymer 3D printing solutions, and Siemens Healthineers, a global provider of medical imaging technology, have introduced patient-specific 3D printed phantoms designed to enhance computed tomography (CT) imaging. Research presented at the Radiological Society of North America (RSNA) annual meeting demonstrates the accuracy of these models, which replicate human anatomy with high precision.
Researchers at Pusan National University (PNU) have developed a way to 3D print fat tissue that could speed up wound healing, offering potential relief for patients with chronic injuries and burns.
Lincotek’s Medical Division has secured a patent for a 3D printed screw designed to enhance bone ingrowth and offer greater customization for orthopedic procedures.
CAD-Ray, a provider of digital dentistry solutions with over 100 years of experience in dental scanning and milling, and Zylo3D, a company founded in 2023 specializing in automated, all-in-one chairside 3D printing, have partnered to offer a comprehensive dental 3D printing solution. This new solution integrates Zylo3D’s AI-driven software with CAD-Ray’s focus on affordability.
Chinese drug 3D printing firm Triastek has announced that its 3D printed drug product, D23, Budesonide Ileum Targeted Tablets for the treatment of IgAN (Immunoglobulin A Nephropathy)—a kidney disorder characterized by the buildup of immunoglobulin A (IgA) deposits in the kidneys—has demonstrated favorable results in a recent clinical study.